GBSN bought back because of the 6 FDA,s looking buyout merger, projected revs outstanding orders on latest FDA,large #patents which make them the leading provider in the molecular diagnosis space,and revs to boot with a cleaner balance sheet
“paper’ll lay down and let you write whatever you want on it.”